Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 4/2003

01-11-2003 | Review Article

Dominant β-Thalassemia with Hemoglobin Hradec Kralove: Enhanced Hemolysis in the Spleen

Authors: Shouichi Ohga, Akihiko Nomura, Hidetoshi Takada, Junko Kato, Hiroshi Ideguchi, Yukio Hattori, Masahiro Suda, Sachiyo Suita, Toshiro Hara

Published in: International Journal of Hematology | Issue 4/2003

Login to get access
Metadata
Title
Dominant β-Thalassemia with Hemoglobin Hradec Kralove: Enhanced Hemolysis in the Spleen
Authors
Shouichi Ohga
Akihiko Nomura
Hidetoshi Takada
Junko Kato
Hiroshi Ideguchi
Yukio Hattori
Masahiro Suda
Sachiyo Suita
Toshiro Hara
Publication date
01-11-2003
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2003
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/BF02983557

Other articles of this Issue 4/2003

International Journal of Hematology 4/2003 Go to the issue

Case Report

Detection of Two Cell Populations Corresponding to Distinct Maturation Stages in API-2/MLT-Positive Mucosa-Associated Lymphoid Tissue Lymphoma Cells Proliferating in Pleural Effusion

Case Report

Rituximab Treatment for Relapsed Autoimmune Hemolytic Anemia in Evans Syndrome

Case Report

Monitoring Minimal Residual Disease in Leukemia Using Real-time Quantitative Polymerase Chain Reaction for Wilms Tumor Gene (WT1)

In Memorium

A Tribute to the Memory of Hisamaru Hirai, MD, PhD Professor of the Department of Hematology and Oncology Graduate School of Medicine, The University of Tokyo

OriginalPaper

T-Cell Control by Human T-Cell Leukemia/Lymphoma Virus Type 1

Case Report

Immunophenotypes and Outcome of Philadelphia Chromosome-Positive and -Negative Thai Adult Acute Lymphoblastic Leukemia
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits